Contact
searchSearch
HMP Global
Quiz

Making Sense of HECSI Scores in Trials

Riya Gandhi, MA
07/15/2025

Related Content

NEA Approved Features
Supporting the Transition to Self- Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
Dr Glick
Conference Coverage
Rethinking Seborrheic Dermatitis in 2026: PDE4 Inhibitors, Luliconazole, and Microbiome-Driven Care
02/19/2026
Riya Gandhi, MA
A clinical update on seborrheic dermatitis, featuring roflumilast foam, luliconazole shampoo, JAK inhibitors, biologics, and microbiome-targeted therapies.
A clinical update on seborrheic dermatitis, featuring roflumilast foam, luliconazole shampoo, JAK inhibitors, biologics, and microbiome-targeted therapies.
A clinical update on seborrheic...
02/19/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist

Popular Articles

skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
Case Report
Treatment of Recurrent Erythema Multiforme in an Immunosuppressed Patient
05/06/2024
Steven R. Feldman, MD, PhD
We present a recurrent case of this acute, type IV hypersensitivity reaction with extensive cutaneous and oral involvement in a patient on infliximab despite standard antiherpetic treatment.
We present a recurrent case of this acute, type IV hypersensitivity reaction with extensive cutaneous and oral involvement in a patient on infliximab despite standard antiherpetic treatment.
We present a recurrent case of...
05/06/2024
The Dermatologist
Case Report
Stage II Hodgkin Lymphoma and Bleomycin-Induced Flagellate Rash
06/06/2024
Danielle Randolph; Sandra Marchese Johnson, MD, FAAD; Katharin Janda, MD
New onset of pruritus and weight loss in a healthy young person should prompt an investigation for underlying causes of itch.
New onset of pruritus and weight loss in a healthy young person should prompt an investigation for underlying causes of itch.
New onset of pruritus and weight...
06/06/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.15% for Treatment of Atopic Dermatitis in Adults and Children Aged 6 and Older
07/09/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug...
07/09/2024
The Dermatologist
Surgical Pearls
Optimizing Dermatologic Surgery Care
09/06/2024
Riya Gandhi, MA
Gain valuable insights to enhance patient outcomes and stay informed about the evolving landscape of dermatologic surgery.
Gain valuable insights to enhance patient outcomes and stay informed about the evolving landscape of dermatologic surgery.
Gain valuable insights to...
09/06/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use